Gillespie M T, Horwood N J
St. Vincent's Institute of Medical Research and The University of Melbourne, Department of Medicine, St. Vincent's Hospital, Fitzroy, Vic, Australia.
Cytokine Growth Factor Rev. 1998 Jun;9(2):109-16. doi: 10.1016/s1359-6101(98)00004-5.
Just over two years ago the newest member of the interleukin family of cytokines, IL-18, was molecularly cloned. IL-18 was originally identified as a result of its ability to induce interferon gamma production, however with the advent of its cloning and the production of recombinant protein a number of other biological actions have since been identified. Recently the receptor for IL-18 was also characterised. Due to the structural and biological properties shared between IL-18 and IL-1 and their respective receptors, questions relating to IL-18 activities are being answered at a rapid pace. This article addresses the biology of IL-18 in both disease and non-disease states.
就在两年多以前,细胞因子白细胞介素家族的最新成员白细胞介素-18(IL-18)被成功进行了分子克隆。IL-18最初是因其诱导γ干扰素产生的能力而被发现的,然而随着其克隆技术的出现以及重组蛋白的产生,此后又发现了许多其他生物学作用。最近,IL-18的受体也得到了鉴定。由于IL-18与IL-1及其各自受体之间存在共同的结构和生物学特性,与IL-18活性相关的问题正得到迅速解答。本文阐述了IL-18在疾病和非疾病状态下的生物学特性。